Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: One investor learns of the date

for the ASHM through a private letter and shares this with all of us. How come the "company" has Not deemed it important enough to let all shareholders know of the meeting date? Or, did I miss the date in the latest filing? (corrections welcome).

Share
New Message
Please login to post a reply